Check out these key findings about Elevance Health Inc (ELV)

With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.02 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $539.87 whereas the lowest price it dropped to was $524.97. The 52-week range on ELV shows that it touched its highest point at $550.34 and its lowest point at $412.00 during that stretch. It currently has a 1-year price target of $611.41. With its current market cap of 123.25 billion, ELV has annualized dividend of $6.22 while the current yield stands at 1.17%. ELV paid its most recent dividend on 1717977600, while the ex-dividend date for that was 1717977600. Beta for the stock currently stands at 0.85.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ELV was down-trending over the past week, with a drop of -0.75%, but this was down by -2.29% over a month. Three-month performance surged to 4.80% while six-month performance rose 10.75%. The stock gained 19.31% in the past year, while it has gained 12.46% so far this year. A look at the trailing 12-month EPS for ELV yields 26.46 with Next year EPS estimates of 41.64. For the next quarter, that number is 10.02. This implies an EPS growth rate of 12.49% for this year and 11.71% for next year. EPS is expected to grow by 12.10% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 12.18%.

Float and Shares Shorts:

At present, 233.07 million ELV shares are outstanding with a float of 231.34 million shares on hand for trading. On 2024-06-14, short shares totaled 2.28 million, which was 98.0 higher than short shares on 1715731200. In addition to Ms. Gail Koziara Boudreaux as the firm’s President, CEO & Director, Mr. Mark Bradley Kaye serves as its Executive VP & CFO.

Institutional Ownership:

Through their ownership of 0.91457003 of ELV’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ELV since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.